Webinar: Using CRISPR to Develop Personalized Treatments by LabX Media Group

Host Login

About This Webinar

Correcting a mutation in a patient with a debilitating disease used to seem like science fiction, but the advent of CRISPR editing made this dream a reality. In this webinar, experts will review recent advances in and applications of CRISPR for drug screening and correcting mutations in diseased patients.

Topics to be covered

• Unbiased CRISPR screening approaches for novel therapeutic target discovery
• Finding an HIV cure using CRISPR

Presenters

Mazhar Adli, PhD

Associate Professor, Department of Obstetrics and Gynecology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine at Northwestern University

Mazhar Adli is an associate professor at Northwestern Medical School, the Robert H. Lurie Comprehensive Cancer Center, and the Department of Obstetrics and Gynecology. Adli joined the Feinberg School of Medicine in January of 2020. His research group pioneered efforts to map and identify genome-wide Cas9 off-targets and binding specificities and developed computational CRISPR off-target prediction tools. Aldi aims to understand key drivers of aberrant genome regulation in disease settings such as cancer. To achieve this, his team utilizes genomic and epigenomic mapping, editing, and imaging approaches to understand genome regulation in normal and cancer settings.

William Dampier, PhD

Assistant Professor, Department of Microbiology and Immunology, Drexel University College of Medicine

William Dampier received his PhD from the School of Biomedical Engineering at Drexel University in 2010, where he used machine learning to study public data on HIV genetic variation, its impact on treatment outcomes, and host binding partners. He joined the faculty of the Drexel College of Medicine in 2012 and began applying his techniques with a large HIV patient cohort in collaboration with Brian Wigdahl, professor and chair of the Department of Microbiology & Immunology at Drexel University College of Medicine. Dampier’s current research focuses on curing HIV using CRISPR-Cas9 gene editing and how to address the challenges of HIV genetic variation.